Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.

Jong Hyuk LeeJae-Joon YimJimyung Park

Published in: Respiratory research (2022)

A substantial number of COVID-19 survivors displayed pulmonary sequelae as part of PACS. Except for restrictive pulmonary dysfunction, the prevalence of these sequelae did not decrease until 1 year after initial infection. Considering the association between the severity of acute COVID-19 and risk of pulmonary sequelae, patients who recover from severe COVID-19 require close respiratory follow-up. Systematic review registration number PROSPERO CRD42021234357.

Keyphrases

coronavirus disease
sars cov
systematic review
pulmonary hypertension
computed tomography
respiratory syndrome coronavirus
oxidative stress
risk factors
drug induced
positron emission tomography
meta analyses
early onset
intensive care unit
respiratory failure